BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 9191525)

  • 1. Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. French Federation of Cancer Centers (FNCLCC) Sarcoma Group.
    Collin F; Chassevent A; Bonichon F; Bertrand G; Terrier P; Coindra JM
    Cancer; 1997 Jun; 79(12):2371-9. PubMed ID: 9191525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.
    Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E
    Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major salivary gland lesions: correlation of MR findings with flow cytometric DNA analysis and prognosis.
    Takashima S; Sone S; Horii A; Okamoto S; Yoshida J
    AJR Am J Roentgenol; 1996 Nov; 167(5):1297-304. PubMed ID: 8911200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns.
    Michels JJ; Marnay J; Plancoulaine B; Chasle J
    Cytometry B Clin Cytom; 2004 May; 59(1):32-9. PubMed ID: 15108168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma.
    Kaern J; Tropé CG; Kristensen GB; Pettersen EO
    Cancer; 1994 Apr; 73(7):1870-7. PubMed ID: 8137213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
    Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
    J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG; Toth M; Flynn S; Fischer D; Carter D
    J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome.
    Huuhtanen RL; Blomqvist CP; Wiklund TA; Virolainen MJ; Elomaa AI; Pan Y; Tribukait B
    Cancer; 1996 May; 77(9):1815-22. PubMed ID: 8646679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical relevance of ploidy and S-phase fraction determination in salivary gland tumors: a flow cytometric study of 97 cases.
    Pinto AE; Fonseca I; Soares J
    Cancer; 1999 Jan; 85(2):273-81. PubMed ID: 10023692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors.
    Kroese MC; Rutgers DH; Wils IS; Van Unnik JA; Roholl PJ
    Cancer; 1990 Apr; 65(8):1782-8. PubMed ID: 2156603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients.
    Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P
    Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.
    Coindre JM; Terrier P; Bui NB; Bonichon F; Collin F; Le Doussal V; Mandard AM; Vilain MO; Jacquemier J; Duplay H; Sastre X; Barlier C; Henry-Amar M; Macé-Lesech J; Contesso G
    J Clin Oncol; 1996 Mar; 14(3):869-77. PubMed ID: 8622035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
    Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
    Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study.
    Russo A; Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Latteri F; Valerio MR; Pantuso G; Morello V; Dardanoni G; Latteri MA; Colucci G; Tomasino RM; Gebbia N
    Cancer; 2001 Jul; 92(2):294-302. PubMed ID: 11466682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of DNA ploidy and S-phase fraction in primary localized myxofibrosarcoma: correlations with clinicopathological factors, Skp2 expression, and patient survival.
    Huang HY; Huang WW; Wu JM; Huang CK; Wang JW; Eng HL; Lin CN; Chou SC; Yu SC; Fang FM; Lee JC; Li CF
    Ann Surg Oncol; 2008 Aug; 15(8):2239-49. PubMed ID: 18516647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma.
    Pinto AE; Chaves P; Fidalgo P; Oliveira AG; Leitão CN; Soares J
    Dis Colon Rectum; 1997 Apr; 40(4):411-9. PubMed ID: 9106689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
    Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
    Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between histologic grade and cytofluorometric cellular DNA and RNA content in primary bone tumors.
    Takeshita H; Kusuzaki K; Kuzuhara A; Tsuji Y; Ashihara T; Gebhardt MC; Mankin HJ; Springfield DS; Hirasawa Y
    Anticancer Res; 2001; 21(2B):1271-7. PubMed ID: 11396198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.